查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1465134

依普拉嗪市場：按適應症、產品、分銷管道和管理方法分類 - 2024-2030 年全球預測

Eprazinone Market by Indication (Bronchial asthma, Chronic / acute cough, Chronic respiratory failure), Product (Liquid, Tablet), Distribution Channel, Mode of Administation - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年依拉嗪酮市場規模為172.3億美元，預計2024年將達186億美元，2030年將達297.5億美元，複合年成長率為8.11%。

依普拉嗪酮是一種黏液溶解和祛痰藥物，用於治療以黏液黏稠為特徵的呼吸道疾病，例如慢性阻塞性肺病（COPD）和支氣管炎。透過破壞黏液結構，促進氣道清除，改善症狀和呼吸功能。全球慢性阻塞性肺病、氣喘和支氣管炎等疾病的快速增加增加了對依拉嗪酮的需求。製藥業不斷增加的研究和開發導致埃拉嗪酮配方的改進和更有效，預計將為市場成長創造機會。由於潛在的副作用，包括胃腸道不適和過敏，依拉嗪酮在某些人群中的使用受到限制。藥品核准的嚴格監管要求減緩了新製劑的推出，並阻礙了某些地區的市場進入。市場供應商開拓的依拉嗪新配方預計將創造市場成長機會。

主要市場統計
基準年[2023] 172.3億美元
預測年份 [2024] 186億美元
預測年份 [2030] 297.5億美元
複合年成長率（%） 8.11%

適應症 支氣管氣喘治療中對依拉嗪酮的需求不斷增加。

在支氣管氣喘的治療中，依拉嗪酮可減少發炎、放鬆氣道並緩解患者的呼吸過程。依普拉嗪是一種治療慢性咳嗽和急性咳嗽的藥物，可減少咳嗽的頻率和嚴重程度。對於慢性呼吸衰竭患者，依拉嗪可改善呼吸功能，提升生活品質。依普拉嗪作為黏液溶解劑，可促進痰液清除過程，是治療與各種呼吸道疾病相關的咳嗽的有效解決方案。由於其對慢性和急性支氣管炎具有祛痰作用，依拉嗪酮是慢性和急性支氣管炎患者的基本藥物，有助於清除肺部黏液。在流感期間，依拉嗪可緩解咳嗽症狀並有助於控制上呼吸道疾病。依普拉嗪也可用於治療鼻炎，緩解鼻塞和其他相關症狀，並使呼吸更順暢。

依普拉錠劑產品因其方便且劑量精確而受到偏好。

液體依拉嗪酮是一種黏液溶解和祛痰藥物，易於吞嚥且起效快。專為吞嚥錠劑有困難或喜歡液體藥物的患者而設計。該配方對兒童和老年人特別有益。液體形式可以靈活給藥，以滿足患者的特定需求和嚴重程度。依普拉錠劑是一種方便且給藥精確的藥物，非常適合治療與黏液分泌過多相關的呼吸道疾病。錠劑是首選，因為它們易於運輸、具有穩定的保存期限並且提供一致的劑量。錠劑通常是開給成人的，適合能夠遵守定期給藥方案的患者。依普拉錠劑旨在促進系統釋放和吸收，確保持續的治療效果。

區域洞察

美洲依拉嗪酮市場需求穩定，主要得益於製藥業的成長和先進的醫療基礎設施、人們對呼吸系統疾病的廣泛認知以及大型製藥公司的存在。南美洲也為市場成長做出了貢獻，巴西和墨西哥等國家擴大了醫療設施並增加了藥品的取得。監管支持和不斷成長的醫療保健支出也是促進依拉嗪酮在美洲成長的因素。在亞太地區，中國、印度和日本等國家呼吸系統疾病的增加、老年人口的增加、醫療基礎設施的改善以及可支配收入的增加正在促進依拉地農市場的快速成長。製藥業的擴張和政府對醫療保健的有利政策也是推動該地區市場成長的重要因素。在研發投資增加和醫療改革的推動下，亞太地區市場預計在未來幾年將顯著成長。歐洲、中東和非洲地區為依拉嗪提供了多元化的市場環境。歐洲是一個強大的市場，因為其完善的醫療保健系統、對肺部疾病的高度認知以及專注於呼吸護理的大型製藥企業的存在。儘管中東和非洲的市場規模小於歐洲，但由於醫療基礎設施的改善、醫療支出的增加以及藥品取得的增加，其市場規模正在不斷成長。此外，支持藥物核准和商業化的監管政策正在對歐洲、中東和非洲依拉嗪酮市場產生積極影響。

FPNV定位矩陣

FPNV定位矩陣對於評估依拉嗪酮市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對依拉嗪酮市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1. 依拉嗪酮市場規模及預測為何？

2.在Eprrazinone市場的預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3. 依拉嗪酮市場的技術趨勢和法規結構是什麼？

4.依普拉嗪酮市場主要廠商的市場佔有率為何？

5.進入依拉嗪酮市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地呼吸系統疾病的發生率正在上升
      • 加大投資擴大醫藥領域
    • 抑制因素
      • 與依拉嗪酮相關的處方藥物高成本
    • 機會
      • 依拉嗪酮新劑型開發取得進展
      • 增加依拉嗪酮的監管核准
    • 任務
      • 對依拉嗪酮益處的認知有限
  • 市場區隔分析
    • 適應症：用於治療支氣管氣喘、減少發炎和放鬆氣道的依拉嗪酮需求增加
    • 產品：優選依拉嗪片，因為它們可以精確調整藥物劑量。
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 依拉嗪市場適應症

  • 支氣管氣喘
  • 慢性/急性咳嗽
  • 慢性呼吸衰竭
  • 咳嗽
  • 慢性/急性支氣管炎的祛痰藥
  • 流感
  • 鼻炎

第7章 依拉嗪市場：依產品

  • 液體
  • 藥片

第8章依拉嗪市場：按分銷管道

  • 電子商務平台
  • 醫院藥房
  • 網路藥房

第9章 依拉嗪酮市場管理方法

  • 靜脈
  • 口服

第10章 美洲依拉嗪酮市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區依拉嗪酮市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲依拉嗪酮市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Biosynth 收購 Biochemicals 加強供應鏈服務
    • Accelerated Access Collaborative 宣布投資 1,100 萬歐元用於中風、心血管和呼吸系統疾病創新
  • 戰略分析和建議

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-F97DD5A7D578

[189 Pages Report] The Eprazinone Market size was estimated at USD 17.23 billion in 2023 and expected to reach USD 18.60 billion in 2024, at a CAGR 8.11% to reach USD 29.75 billion by 2030.

Eprazinone is a mucolytic and expectorant medication utilized in the treatment of respiratory diseases characterized by thickened mucus, such as chronic obstructive pulmonary disease (COPD) and bronchitis. By breaking down the structure of mucus, it facilitates easier clearance of the airways, improving symptoms and respiratory function. The global surge in conditions, including COPD, asthma, and bronchitis, is driving the need for eprazinone. Rising research and development within the pharmaceutical industry that leads to improved and more effective formulations of eprazinone is expected to create opportunities for market growth. The potential side effects associated with Eprazinone, including gastrointestinal disturbances and allergy risks, limit its use in certain populations. Stringent regulatory requirements for drug approval delay the introduction of new formulations and hinder market entry in certain regions. The growing development of new formulations of eprazinone by market vendors is expected to create opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 17.23 billion
Estimated Year [2024] USD 18.60 billion
Forecast Year [2030] USD 29.75 billion
CAGR (%) 8.11%

Indication: Rising need for eprazinone for the management of bronchial asthma to reduce inflammation and relax the airways

In the management of bronchial asthma, eprazinone helps reduce inflammation and relax the airways, easing the breathing process for patients. Eprazinone serves as a therapeutic agent in relieving both chronic and acute cough, reducing the frequency and severity of cough episodes. For patients experiencing chronic respiratory failure, eprazinone aids in improving respiratory function and enhancing the quality of life. Acting as a mucolytic, eprazinone facilitates the expectoration process, making it an effective solution for managing cough related to various respiratory conditions. Expectorant in chronic/acute bronchitis' expectorant properties make eprazinone an essential medication for patients suffering from both chronic and acute bronchitis, helping to clear mucus from the lungs. During flu episodes, eprazinone can provide symptomatic relief from coughing and assist in the management of upper respiratory tract issues. Eprazinone is also indicated in treating rhinitis, where it helps in alleviating nasal congestion and other related symptoms, facilitating easier breathing.

Product: Expanding preference for eprazinone tablets as they offer a convenient and precisely dosed form of the medication

Liquid eprazinone is a mucolytic and expectorant medication formulated for ease of ingestion and rapid action. It is designed for patients who have difficulty swallowing tablets or have a preference for liquid medication. This formulation is especially beneficial for pediatric and geriatric populations. The liquid form allows for flexible dosing tailored to the specific needs and severity of the patient's condition. Eprazinone tablets offer a convenient and precisely dosed form of the medication, ideal for the treatment of respiratory conditions with excessive mucus production. Tablets are favored for their ease of transport, stable shelf life, and consistent dosing. They are often prescribed to adults and are suited for patients able to adhere to a regular medication schedule. The tablet form of Eprazinone is designed to facilitate systematic release and absorption, ensuring a sustained therapeutic effect.

Regional Insights

The Americas' market for eprazinone has shown consistent demand, mainly driven by the growing pharmaceutical industry and its advanced healthcare infrastructure, widespread awareness of respiratory conditions, and the presence of leading pharmaceutical companies. South America also contributes to the market growth, with countries including Brazil and Mexico expanding their healthcare facilities and increasing accessibility to medications. Regulatory support and the growing healthcare expenditure are other factors contributing to the growth of Eprazinone in the Americas. In the APAC region, the eprazinone market is experiencing rapid growth attributed to the increasing prevalence of respiratory diseases, growing elderly population, improvements in healthcare infrastructure, and rising disposable income in countries such as China, India, and Japan. The expansion of the pharmaceutical industry and favorable government policies toward healthcare are also significant factors driving market growth in this region. The APAC market is expected to witness substantial growth in the coming years, fueled by increased investment in R&D and healthcare reforms. The EMEA region presents a diverse market landscape for Eprazinone. Europe is a strong market due to its well-established healthcare systems, high awareness regarding pulmonary diseases, and the presence of major pharmaceutical companies focusing on respiratory care. The Middle East and Africa, though smaller markets compared to Europe, are witnessing growth due to improving healthcare infrastructure, rising healthcare spending, and increasing access to medications. Moreover, regulatory policies supporting drug approval and commercialization are positively impacting the Eprazinone market in EMEA.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Eprazinone Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Eprazinone Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Eprazinone Market, highlighting leading vendors and their innovative profiles. These include BenchChem, Biosynth Ltd, BOC Sciences, Clearsynth, HK Starshine Printing Design Co., Ltd., J&H CHEM Co., Ltd., MedicaPharma BV, MuseChem Chemicals, Nordic Biosite, Procurenet Limited, R.R Scientific, LLC, RayBiotech, Inc., and VIVAN Life Sciences.

Market Segmentation & Coverage

This research report categorizes the Eprazinone Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Bronchial asthma
    • Chronic / acute cough
    • Chronic respiratory failure
    • Cough
    • Expectorant in chronic/acute bronchitis
    • Flu
    • Rhinitis
  • Product
    • Liquid
    • Tablet
  • Distribution Channel
    • eCommerce Platforms
    • Hospital Pharmacies
    • Online Pharmacies
  • Mode of Administation
    • Intravenous
    • Oral
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Eprazinone Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Eprazinone Market?

3. What are the technology trends and regulatory frameworks in the Eprazinone Market?

4. What is the market share of the leading vendors in the Eprazinone Market?

5. Which modes and strategic moves are suitable for entering the Eprazinone Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of respiratory diseases worldwide
      • 5.1.1.2. Expanding the pharmaceutical sector with increasing investments
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of formulations of medications associated with eprazinone
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing development of new formulations of eprazinone
      • 5.1.3.2. Rising approvals for eprazinone by regulatory authorities
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness associated with the benefits of eprazinone
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: Rising need for eprazinone for the management of bronchial asthma to reduce inflammation and relax the airways
    • 5.2.2. Product: Expanding preference for eprazinone tablets as they offer a convenient and precisely dosed form of the medication
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Eprazinone Market, by Indication

  • 6.1. Introduction
  • 6.2. Bronchial asthma
  • 6.3. Chronic / acute cough
  • 6.4. Chronic respiratory failure
  • 6.5. Cough
  • 6.6. Expectorant in chronic/acute bronchitis
  • 6.7. Flu
  • 6.8. Rhinitis

7. Eprazinone Market, by Product

  • 7.1. Introduction
  • 7.2. Liquid
  • 7.3. Tablet

8. Eprazinone Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. eCommerce Platforms
  • 8.3. Hospital Pharmacies
  • 8.4. Online Pharmacies

9. Eprazinone Market, by Mode of Administation

  • 9.1. Introduction
  • 9.2. Intravenous
  • 9.3. Oral

10. Americas Eprazinone Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Eprazinone Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Eprazinone Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Biosynth acquires Vio Chemicals to Fortify its Supply Chain Services
    • 13.3.2. Accelerated Access Collaborative announces Euro 11 million investment in stroke, cardiovascular disease and respiratory innovations
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. EPRAZINONE MARKET RESEARCH PROCESS
  • FIGURE 2. EPRAZINONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EPRAZINONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EPRAZINONE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL EPRAZINONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. EPRAZINONE MARKET DYNAMICS
  • FIGURE 7. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL EPRAZINONE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL EPRAZINONE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EPRAZINONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. EPRAZINONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EPRAZINONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EPRAZINONE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL EPRAZINONE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL EPRAZINONE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL EPRAZINONE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL EPRAZINONE MARKET SIZE, BY BRONCHIAL ASTHMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL EPRAZINONE MARKET SIZE, BY BRONCHIAL ASTHMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL EPRAZINONE MARKET SIZE, BY CHRONIC / ACUTE COUGH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL EPRAZINONE MARKET SIZE, BY CHRONIC / ACUTE COUGH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL EPRAZINONE MARKET SIZE, BY CHRONIC RESPIRATORY FAILURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL EPRAZINONE MARKET SIZE, BY CHRONIC RESPIRATORY FAILURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL EPRAZINONE MARKET SIZE, BY COUGH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL EPRAZINONE MARKET SIZE, BY COUGH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL EPRAZINONE MARKET SIZE, BY EXPECTORANT IN CHRONIC/ACUTE BRONCHITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL EPRAZINONE MARKET SIZE, BY EXPECTORANT IN CHRONIC/ACUTE BRONCHITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL EPRAZINONE MARKET SIZE, BY FLU, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL EPRAZINONE MARKET SIZE, BY FLU, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL EPRAZINONE MARKET SIZE, BY RHINITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL EPRAZINONE MARKET SIZE, BY RHINITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL EPRAZINONE MARKET SIZE, BY LIQUID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL EPRAZINONE MARKET SIZE, BY LIQUID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL EPRAZINONE MARKET SIZE, BY TABLET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL EPRAZINONE MARKET SIZE, BY TABLET, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL EPRAZINONE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL EPRAZINONE MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL EPRAZINONE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL EPRAZINONE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL EPRAZINONE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL EPRAZINONE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL EPRAZINONE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL EPRAZINONE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL EPRAZINONE MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL EPRAZINONE MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 79. MEXICO EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 80. MEXICO EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 81. MEXICO EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 82. MEXICO EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 106. AUSTRALIA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 108. AUSTRALIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 110. AUSTRALIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 112. AUSTRALIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 113. CHINA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 114. CHINA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 115. CHINA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 116. CHINA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 117. CHINA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 118. CHINA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 119. CHINA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 120. CHINA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 121. INDIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 122. INDIA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 123. INDIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. INDIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. INDIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. INDIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. INDIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 128. INDIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 129. INDONESIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 130. INDONESIA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 131. INDONESIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. INDONESIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. INDONESIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 134. INDONESIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 135. INDONESIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 136. INDONESIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 137. JAPAN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 138. JAPAN EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 139. JAPAN EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 140. JAPAN EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 141. JAPAN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 142. JAPAN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 143. JAPAN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 144. JAPAN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 145. MALAYSIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 146. MALAYSIA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 147. MALAYSIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. MALAYSIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. MALAYSIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 150. MALAYSIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 151. MALAYSIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 152. MALAYSIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. PHILIPPINES EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. PHILIPPINES EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 158. PHILIPPINES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 160. PHILIPPINES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 161. SINGAPORE EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 162. SINGAPORE EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 163. SINGAPORE EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. SINGAPORE EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. SINGAPORE EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 166. SINGAPORE EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 167. SINGAPORE EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 168. SINGAPORE EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH KOREA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH KOREA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 174. SOUTH KOREA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 176. SOUTH KOREA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 177. TAIWAN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 178. TAIWAN EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 179. TAIWAN EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 180. TAIWAN EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 181. TAIWAN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 182. TAIWAN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 183. TAIWAN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 184. TAIWAN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 185. THAILAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 186. THAILAND EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 187. THAILAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. THAILAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. THAILAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 190. THAILAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 191. THAILAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 192. THAILAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 193. VIETNAM EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 194. VIETNAM EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 195. VIETNAM EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 196. VIETNAM EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 197. VIETNAM EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 198. VIETNAM EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 199. VIETNAM EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 200. VIETNAM EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 211. DENMARK EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 212. DENMARK EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 213. DENMARK EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 214. DENMARK EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 215. DENMARK EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 216. DENMARK EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 217. DENMARK EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 218. DENMARK EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 219. EGYPT EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 220. EGYPT EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 221. EGYPT EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. EGYPT EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. EGYPT EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 224. EGYPT EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 225. EGYPT EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 226. EGYPT EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 227. FINLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 228. FINLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 229. FINLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. FINLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. FINLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 232. FINLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 233. FINLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 234. FINLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 235. FRANCE EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 236. FRANCE EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 237. FRANCE EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. FRANCE EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. FRANCE EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 240. FRANCE EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 241. FRANCE EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 242. FRANCE EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 243. GERMANY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. GERMANY EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. GERMANY EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. GERMANY EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. GERMANY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 248. GERMANY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 249. GERMANY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 250. GERMANY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 251. ISRAEL EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 252. ISRAEL EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 253. ISRAEL EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. ISRAEL EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. ISRAEL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 256. ISRAEL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 257. ISRAEL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 258. ISRAEL EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 259. ITALY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 260. ITALY EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 261. ITALY EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. ITALY EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. ITALY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 264. ITALY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 265. ITALY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 266. ITALY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 268. NETHERLANDS EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. NETHERLANDS EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 272. NETHERLANDS EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 274. NETHERLANDS EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 275. NIGERIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 276. NIGERIA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 277. NIGERIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. NIGERIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. NIGERIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 280. NIGERIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 281. NIGERIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 282. NIGERIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 283. NORWAY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 284. NORWAY EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 285. NORWAY EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. NORWAY EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. NORWAY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 288. NORWAY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 289. NORWAY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 290. NORWAY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 291. POLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 292. POLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 293. POLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 294. POLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 295. POLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 296. POLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 297. POLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 298. POLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 299. QATAR EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 300. QATAR EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 301. QATAR EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 302. QATAR EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 303. QATAR EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 304. QATAR EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 305. QATAR EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 306. QATAR EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 307. RUSSIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 308. RUSSIA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 309. RUSSIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 310. RUSSIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 311. RUSSIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 312. RUSSIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 313. RUSSIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 314. RUSSIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 316. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 318. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 320. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 322. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 324. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 326. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 328. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 330. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 331. SPAIN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 332. SPAIN EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 333. SPAIN EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 334. SPAIN EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 335. SPAIN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 336. SPAIN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 337. SPAIN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 338. SPAIN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 339. SWEDEN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 340. SWEDEN EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 341. SWEDEN EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 342. SWEDEN EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 343. SWEDEN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 344. SWEDEN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 345. SWEDEN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 346. SWEDEN EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 348. SWITZERLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 350. SWITZERLAND EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 351. SWITZERLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 352. SWITZERLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 353. SWITZERLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 354. SWITZERLAND EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 355. TURKEY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 356. TURKEY EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 357. TURKEY EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 358. TURKEY EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 359. TURKEY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 360. TURKEY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 361. TURKEY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 362. TURKEY EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 363. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 364. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 365. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 366. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 367. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 368. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 369. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2018-2023 (USD MILLION)
  • TABLE 370. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY MODE OF ADMINISTATION, 2024-2030 (USD MILLION)
  • TABLE 371. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 372. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 373. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)

T